Home The Jury

The Jury

Broadcasting on CNBC TV18
Pharma GQP Logo Favicon
JURY
The Jury

This approach ensures the integrity of our awards. Winners are selected based on merit, not popularity, by a distinguished panel of 5 veteran leaders with expertise in pharma quality, from regulatory bodies and academia. This proven method ensures deserving recognition and has garnered commendation for its effectiveness.

To make sure no one can influence the jury’s decision, we are keeping the names private. The jury members are qualified personnels with pharma, academic, regulatory body background.

Mr. Ranjit Barshikar

Mr. Ranjit Barshikar

CEO

QbD International

View Profile
Mr. Shirish Belapure

Mr. Shirish Belapure

Sr. Technical Adviser

IPA

View Profile
Mr. SM Mudda

Mr. SM Mudda

Managing Director at Misom Labs Limited, Malta; Chairman IDMA, Regulatory Affairs

View Profile
Dr. Rajiv Desai

Dr. Rajiv Desai

Former EVP & Global Quality Head

Lupin

View Profile
Dr. Atul Kumar Nasa

Dr. Atul Nasa

Vice-Chancellor

SGT University, Gurugram

View Profile
C.

Collaboration

Score based on demonstrated excellence in fostering collaboration within and beyond the organization.
A.

Automation

Score based on the innovative use of automation in quality processes.
S.

Sustainability

Score based on efforts to integrate sustainable practices into pharmaceutical manufacturing.

  • Outline the nominee’s contributions to environmentally sustainable practices in pharmaceutical manufacturing.
  • Describe any initiatives undertaken by the nominee to reduce environmental impact and promote sustainability.
E.

Education

Score based on initiatives to educate and empower the workforce.

Overall Recommendation:
Score based on the overall contribution of the nominee in advancing pharmaceutical quality through Collaboration, Automation, Sustainability, and Education.

Broadcasting on CNBC TV18
Mr. Ranjit Barshikar
CEO, QbD International

Mr. Ranjit Barshikar

With a career spanning 52 years, Mr. Barshikar brings a wealth of experience across various sectors specializing in Quality Management, R&D, Manufacturing, and Regulatory compliance with bodies such as US FDA, EU, and WHO.

Currently, serving as the CEO of QbD International, specializing in Quality by Design and CGMP Consulting for the Bio-Pharma and Pharma sectors, he has been awarded as “Quality Champion – Gold” Award by the Government of India’s Quality Council and the “Lifetime Achievement” Award by the International UNICEF Council-USA.

Additionally, he is an Adviser to the United Nations MPP Geneva and a member of the Editorial Board of the Journal of Generic Medicines in England and his expertise spans various areas including AI in Pharma applications, Quality by Design, Data Integrity, CAPA, Quality Culture, Validations, Continuous Manufacturing PAT, Regulatory affairs, and more.

Throughout his career, he has conducted hundreds of audits and inspections globally at various pharmaceutical sites, including formulations, API, outsourcing labs, and CROs, and has traveled to over 70 countries and delivered numerous presentations and webinars, addressing key topics in the pharmaceutical industry.

He is actively engaged in educational endeavors, serving on advisory boards for institutions such as D.Y. Patil University Pharmacy College and NM Sattha College of Pharmacy. He has also been involved with organizations such as IPA, IDMA, ISPE, and others.

Mr. Shirish Belapure
Sr. Technical Adviser, IPA

Mr. Shirish Belapure

Shirish Belapure, a seasoned professional with over 42 years of experience in the pharmaceutical industry, holds a postgraduate degree in Pharmacy from Nagpur University and a Management Certification from the prestigious Indian Institute of Management (IIM) Ahmedabad. Throughout his illustrious career, he has demonstrated expertise in various areas including formulation development, manufacturing, Quality Assurance, and regulatory affairs of API & formulations.

Currently serving as the Senior Technical Advisor of the Indian Pharmaceutical Alliance, Shirish also holds the role of Venture Partner with “Eight Roads,” a leading private equity firm. Previously, he held the position of Managing Director at Zydus Hospira Oncology Pvt Ltd, a joint venture between Zydus and Pfizer, where he spearheaded operations.

With a rich background working with renowned companies such as Sunpharma, CIPLA, and Lederle, Shirish has led several initiatives contributing to operational excellence and automation in manufacturing processes. Notably, he championed the ‘Strategic Lean Integrated Manufacturing (SLIM)’ initiative at Zydus Manufacturing.

His commitment to the industry is evident through his active involvement in various organizations and initiatives. Shirish served as the President of the PDA India chapter, overseeing the continuation of training programs and online initiatives during the pandemic. He also contributes to academia as a member of the corporate advisory board at Lovely University and holds positions on the board of directors in multiple companies.

Currently, Shirish’s focus lies on driving quality initiatives as part of the Quality Forum in IPA. This includes fostering best practice sharing, organizing advanced GMP workshops, facilitating Industry-Academia collaboration, and conducting training programs for the pharmaceutical industry in collaboration with WHO. His multifaceted experience and dedication make him a respected figure in the pharmaceutical landscape.

Mr. SM Mudda
Managing Director at Misom Labs Limited, Malta; Chairman IDMA, Regulatory Affairs

Mr. SM Mudda

With over four decades of extensive experience in various facets of the pharmaceutical industry, I am deeply committed to implementing best-practice Pharmaceutical Quality Systems (PQS) to foster a culture of quality within organizations. As the Managing Director of Misom Labs Limited, Malta, an EU GMP Certified Pharmaceutical Testing Laboratory, I oversee EU importation, testing, batch release, and GMP audit services.

Previously, I held key positions at Micro Labs Limited, Bangalore, spanning over 33 years, including Executive Director of Technical & Operations and Director of Global Strategy – Technical. Additionally, I have designed and facilitated the successful completion of the first batch of the MBA-Style Advanced Program in Pharmaceutical Quality Management (APPQM) for IDMA in collaboration with NSF, UK.

Throughout my career, I have spearheaded the design of world-class GMP-compliant facilities for various dosage forms and have been a regular speaker, panelist, and moderator at national and international forums on topics ranging from Pharmaceutical Quality Systems to Data Integrity. I have also actively engaged with government bodies and regulators on policy matters related to the pharmaceutical industry, serving as the Chairman of the Regulatory Affairs Committee at IDMA, Mumbai, and as a former board member of ISPE India Affiliate.

Dr. Rajiv Desai
Former EVP & Global Quality Head, Lupin

Dr. Rajiv Desai

Dr Rajiv Desai has around 30 years of experience in the industry. In his previous assignments, he has worked as head of Corporate Quality Management at Lupin, Dr Reddy’s, Mylan, Piramal, and Alembic Pharmaceuticals. He started his career with Ciba Geigy (now Novartis) in R&D and Technology transfers with assignments in India and Switzerland.

His experience spreads across basic research, Technology transfers, Quality Management, and Regulatory affairs. He was a member of the US Pharmacopeia Expert committee between 2010 and 2015. He has been invited to deliver lectures at various international and national scientific forums. He has actively worked on several boards of studies of reputed universities in India for short-term teaching assignments and syllabus revision programs for postgraduate courses. At UDCT, he was appointed as visiting faculty, under the Daiichi Karkaria Memorial Endowment faculty program for the year 2013 – 2014. He has been nominated as an Expert Member in the Indian Pharmacopeia.

Dr. Atul Nasa
Vice-Chancellor, SGT University, Gurugram

Dr. Atul Kumar Nasa

Dr. Atul Nasa brings over 37 years of professional experience to the table. With a Ph.D. in Pharmaceuticals Sciences from Amity University, Noida, and a Postgraduate degree in Pharmacy from Delhi University, Dr. Nasa has held significant roles in both academia and government.

Previously, he served as the Head of the Office/Controlling & Licensing Authority with the Drugs Control Department, Government of NCT of Delhi. Dr. Nasa’s expertise lies in the enforcement of various pharmaceutical regulations, including the Drugs & Cosmetics Act, Drugs (Price Control) Order, Drugs & Magic Remedies (Objectionable Advertisements) Act, and Medical Devices Rules.
He is actively involved in various government committees and councils, including the Drugs Consultative Committee and the Pharmacy Council of India (PCI), where he serves as a member and holds positions in the Executive Committee and the Appellant Committee for the All-India Council for Technical Education.

Dr. Nasa’s commitment to the pharmacy profession extends to his involvement in numerous professional associations, both nationally and internationally. He is a life member of several prestigious organizations, including IPGA, IPA, APTI, IHPA, AIDCOC, ISTE, IPS, Indian Society of Pharmacognosy, and Indian Society of Cosmetology. Additionally, he is a member of the International Pharmaceutical Federation (FIP).

His contributions to the field are not only academic but also extend to training programs, seminars, and consumer awareness initiatives organized by NGOs, Consumer Associations, Academic Institutions, and Government Organizations. Dr. Nasa’s dedication, passion, and tireless efforts continue to drive advancements in the pharmacy profession, making him a respected figure in the industry.